BIOSW | BioPlus Acquisition Corp. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.0008 - 0.0028
52 Week Range	0.0008 - 0.0028
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	398,992
Average Volume	N/A
Shares Outstanding	149,337,259,285
Market Cap	209,072,163
Sector	Financial Services
Industry	Shell Companies
IPO Date	2022-01-24

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	N/A
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	0
Country	USA
Website	BIOSW

BioPlus Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus its search on companies in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.

BIOSW's peers: IVCBW, TLGYW, HAIAW

*Chart delayed

Analyzing fundamentals for BIOSW we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see BIOSW Fundamentals page.

Watching at BIOSW technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on BIOSW Technicals page.